TLSI
TriSalus Life Sciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.08
-0.02 ▼ -0.49%
🌙 3월 13일 6:59 PM ET (한국 3/14 07:59)
$4.16
+0.08 ▲ +1.96%
| Index | RUT | P/E | - | EPS (ttm) | -1.83 | Insider Own | 39.43% | Shs Outstand | 0.05B | Perf Week | -8.62% |
| Market Cap | 0.25B | Forward P/E | - | EPS next Y | 72.05% | Insider Trans | 1.83% | Shs Float | 0.04B | Perf Month | -15% |
| Enterprise Value | 0.26B | PEG | - | EPS next Q | -0.13 | Inst Own | 18.67% | Short Float | 2.66% | Perf Quarter | -43.72% |
| Income | -0.07B | P/S | 5.54 | EPS this Y | 82.5% | Inst Trans | 4.35% | Short Ratio | 5.25 | Perf Half Y | -12.82% |
| Sales | 0.05B | P/B | - | EPS next 5Y | - | ROA | -132.3% | Short Interest | 0.99M | Perf YTD | -41.55% |
| Book/sh | -0.68 | P/C | 12.24 | EPS past 3/5Y | 77.5% -140.62% | ROE | - | 52W High | -48.68% ($7.95) | Perf Year | -23.02% |
| Cash/sh | 0.33 | P/FCF | - | Sales past 3/5Y | 53.85% - | ROIC | -17219.37% | 52W Low | 19.3% ($3.42) | Perf 3Y | -60% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -37.31% | Gross Margin | 84.19% | Volatility(W/M) | 7.66% 7.63% | Perf 5Y | -58.7% |
| Dividend TTM | - | EV/Sales | 5.85 | Sales Y/Y TTM | 53.41% | Oper. Margin | -59.68% | ATR (14) | 0.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.54 | EPS Q/Q | 47.33% | Profit Margin | -157.51% | RSI (14) | 33.55 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.8 | Sales Q/Q | 59.85% | SMA20 | -14.92% ($4.8) | Beta | 0.5 | Target Price | $10.1 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -21.1% ($5.17) | Rel Volume | 0.91 | Prev Close | $4.1 |
| Employees | 102 | LT Debt/Eq | - | EPS/Sales Surpr. | -47.89% 3.04% | SMA200 | -20.95% ($5.16) | Avg Volume(3M) | 0.19M | Price | $4.08 |
| IPO | 2021/2/8 | Option/Short | No/Yes | Trades | 1351 | Volume | 170,489 | Change | -0.49% |
뉴스 로딩 중...